About the Authors

Rogério S. Rosada

Affiliation Núcleo de Pesquisa em Tuberculose, Departamento de Bioquímica e Imunologia, Universidade de São Paulo, São Paulo, Brazil

Ana P. Moreira

Affiliation Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America

Fabiani G. Frantz

Affiliation Núcleo de Pesquisa em Tuberculose, Departamento de Bioquímica e Imunologia, Universidade de São Paulo, São Paulo, Brazil

Raj K. Puri

Affiliation Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Food and Drug Administration, Bethesda, Maryland, United States of America

Aquilur Rahman

Affiliation NeoPharm Inc., Lake Bluff, Illinois, United States of America

Theodore J. Standiford

Affiliation Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States of America

Carlos R. Zárate-Bladés

Affiliation Núcleo de Pesquisa em Tuberculose, Departamento de Bioquímica e Imunologia, Universidade de São Paulo, São Paulo, Brazil

Célio L. Silva

Affiliation Núcleo de Pesquisa em Tuberculose, Departamento de Bioquímica e Imunologia, Universidade de São Paulo, São Paulo, Brazil

Cory M. Hogaboam

hogaboam@umich.edu

Affiliation Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America

Competing Interests

Aquil Rahman is an employee of NeoPharm, Inc., USA, and he was involved in the design of the experiments reported in this manuscript. All other authors have no conflicts of interest pertaining to this manuscript. They adhere to all policies of PLoS ONE involving the sharing of data and materials.

Author Contributions

Conceived and designed the experiments: RSR AR CMH. Performed the experiments: RSR APM FGF RKP CMH. Analyzed the data: RSR APM FGF TS CRZB CMH. Contributed reagents/materials/analysis tools: RKP AR TS CLS CMH. Wrote the paper: RSR APM FGF CRZB CLS CMH.